Related Experiment Video
Updated: Apr 20, 2026

12:04
Mouse Genome Engineering Using Designer Nucleases
Published on: April 2, 2014
29.5K
Donor plasmid design for codon and single base genome editing using zinc finger nucleases
Shondra M Pruett-Miller1, Gregory D Davis
1Department of Genetics, Genome Engineering and iPSC Center, Washington University School of Medicine, St. Louis, MO, USA.
Methods in Molecular Biology (Clifton, N.J.)
|November 20, 2014
Summary
Zinc finger nuclease (ZFN) technology enables precise genome editing for creating point mutations. This study explores practical limitations in delivering genetic information for nuclease-donor gene editing applications.
Area of Science:
- Genetics
- Molecular Biology
- Bioengineering
Background:
- Advances in targeted nuclease technologies like zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and CRISPR/Cas systems allow precise double-strand breaks (DSBs) in the human genome.
- High-resolution ZFN engineering facilitates point mutations within 50 bp of target sites, leveraging mammalian DNA repair pathways.
- The widespread deployment of these technologies necessitates understanding the practical challenges of delivering donor DNA to DSB sites.
Purpose of the Study:
- To investigate the practical limitations of delivering plasmid-based genetic information to chromosomal double-strand break sites.
- To explore a ZFN-compatible donor design for precise genetic modifications.
- To demonstrate codon changes at an endogenous locus using nuclease-donor methods.
Main Methods:
- Utilized CompoZr zinc finger nuclease (ZFN) technology for targeted DNA cleavage.
- Designed and tested a ZFN-compatible donor DNA construct.
- Applied the nuclease-donor method to introduce codon changes at the endogenous human RSK2 kinase locus.
Main Results:
- Demonstrated the capability to place user-defined double-strand breaks at specific genomic locations with high resolution.
- Successfully introduced point mutations (codon changes) into the human RSK2 gene using the developed ZFN-compatible donor system.
- Identified practical considerations for delivering donor DNA in nuclease-mediated gene editing.
Conclusions:
- Nuclease-donor gene editing methods, particularly with ZFNs, offer a powerful approach for precise genomic modifications, including point mutations.
- Understanding and overcoming the limitations of donor DNA delivery is crucial for the broad application of these technologies in research and therapeutics.
- The explored ZFN-compatible donor design provides a foundation for future gene editing strategies at endogenous loci.
Related Concept Videos
CRISPR/Cas9 Genome Editing
3.4K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
3.4K
Conservative Site-specific Recombination and Phase Variation
7.4K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
7.4K
CRISPR
60.5K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
60.5K

